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Hematopoietic stem cells (HSCs) are responsi-
ble for the life-long maintenance and regenera-
tion of the adult vertebrate blood system. HSCs 
are generated through a natural transdifferenti-
ation process occurring in specialized embryonic 
vascular cells, known as hemogenic endothelial 
cells (ECs [HECs]). In mice, the first adult HSCs 
are generated in the aorta-gonad-mesonephros 
(AGM) region at embryonic day (E) 10.5 (Müller 
et al., 1994; Medvinsky and Dzierzak, 1996). 
The emergence of the definitive hematopoietic 
system in the mouse embryo correlates with 
the temporal appearance of clusters of hemato-
poietic cells (HCs) associated with the aortic en-
dothelium and the major arteries (Garcia-Porrero 
et al., 1995; North et al., 1999; de Bruijn et al., 
2000). Chick embryo dye-marking studies were 
the first to show that aortic ECs give rise to HCs 
( Jaffredo et al., 1998). In mammalian embryos, 
the results of phenotypic and genetic studies, 
supported by stringent in vivo transplantation 
studies of enriched cell fractions, demonstrate 
that HSCs are derived from vascular ECs dur-
ing a short window of developmental time (de 
Bruijn et al., 2002; North et al., 2002; Zovein 
et al., 2008; Chen et al., 2009). This develop-
mental process is known as endothelial to hema-
topoietic cell transition (EHT).
To facilitate the study of HSC emergence 
in the mouse embryo, numerous markers have 
been used individually and/or in combination 
to identify HSCs and their direct precursors. 
Immunolocalization of these markers in the 
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Hematopoietic stem cells (HSCs) are generated via a natural transdifferentiation process 
known as endothelial to hematopoietic cell transition (EHT). Because of small numbers of 
embryonal arterial cells undergoing EHT and the paucity of markers to enrich for hemo-
genic endothelial cells (ECs [HECs]), the genetic program driving HSC emergence is largely 
unknown. Here, we use a highly sensitive RNAseq method to examine the whole transcrip-
tome of small numbers of enriched aortic HSCs, HECs, and ECs. Gpr56, a G-coupled protein 
receptor, is one of the most highly up-regulated of the 530 differentially expressed genes. 
Also, highly up-regulated are hematopoietic transcription factors, including the “heptad” 
complex of factors. We show that Gpr56 (mouse and human) is a target of the heptad 
complex and is required for hematopoietic cluster formation during EHT. Our results iden-
tify the processes and regulators involved in EHT and reveal the surprising requirement for 
Gpr56 in generating the first HSCs.
© 2015 Solaimani Kartalaei et al. This article is distributed under the terms of 
an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first 
six months after the publication date (see http://www.rupress.org/terms). After 
six months it is available under a Creative Commons License (Attribution– 
Noncommercial–Share Alike 3.0 Unported license, as described at http://creative-
commons.org/licenses/by-nc-sa/3.0/).
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close attachment to (juxtaposed) or a position distal from the 
endothelium. The total number of GFP+ cells increased from 
287 at early E10 (32 sp [somite pairs]) to 1,592 at late E10 (37 sp; 
Fig. 1 D). From the small fraction of ECs that express GFP 
(range 13–19%), most aortic GFP+ cells are flat ECs with only 
8% of GFP+ cells in hematopoietic clusters. Although by a ran-
dom distribution more GFP+ cluster cells would be expected 
in distal positions (as compared with juxtaposed), we observed 
70–88% of the GFP+ HCs localized in a juxtaposed position, 
most likely because GFP+ HCs are emerging from GFP+ ECs 
and/or are actively maintained at the juxtaposed position.
Because all HSCs are GFP+ and rare HCs have been ob-
served to emerge from GFP+ ECs, Ly6aGFP is the best marker 
for high enrichment of HECs. Hence, we developed an en-
richment method using the Ly6aGFP, cKit, and CD31 mark-
ers: ECs (CD31+cKitGFP), HECs (CD31+cKitGFP+), 
HSCs (CD31+cKit+GFP+), and progenitor/differentiated HCs 
(CD31+cKit+GFP; Fig. 1 B). The distinct cell types were 
sorted (Fig. 1 E) and hematopoietic function was assessed. 
Hematopoietic progenitors were found in the HC (64%) and 
HSC (33%) fractions as expected, with a majority of the 
immature progenitors (CFU-GEMM) in the HSC fraction 
(Fig. 1 F). In vivo transplantation assays revealed that only the 
CD31+cKit+GFP+ fraction contained HSCs (Fig. 1 G). These 
HSCs provided long-term high-level multilineage repopu-
lation of adult irradiated recipients (Fig. S1 A; 6 engrafted 
of 10 injected with 1–5 ee [embryo equivalents]). Despite 
injection of high embryo equivalents of cells from the other 
fractions (4–9 ee), no repopulation was found with the ECs, 
HECs, or HCs.
RNA sequencing and validation
Sorted ECs, HECs, HSCs, and HCs from three independent 
biological replicates were used for RNA sequencing. As few as 
4–14 E10.5 AGM equivalents (34–41 sp) of sorted cells per 
replicate were obtained, and cDNA was made from as few as 
593 sorted cells (see Table S1 for details). The sequence reads of 
EHT cell fractions were mapped to the mouse genome (NCBI 
build 37/mm9), and the generated count table (with 7–57 
million unique mapped reads to exons per sample) was normal-
ized and analyzed by edgeR (Fig. 2 A; McCarthy et al., 2012).
To confirm that the transcriptome analysis was represen-
tative of the sorted EHT fractions, we measured the normalized 
number of fragments (in FPKMs [fragments per kilobase 
exon reads per million fragments mapped]) of CD31, cKit, 
and Ly6a (Fig. 1 H). As expected, CD31 transcripts were 
found in all four subsets (ECs, HECs, HSCs, and HCs), cKit 
transcripts were found only in HCs and HSCs, and Ly6a tran-
scripts were found in HECs and HSCs.
Gene transcript reads for endothelial genes Cdh5, Tek, 
Esam, Kdr, and Eng were highest in HECs as compared with 
ECs and were higher in HSCs than in ECs or HCs. When the 
four cell fractions were examined by FACS (Fig. 1 I), cell sur-
face expression correlated significantly with transcript levels 
(r2 = 0.54, P = 0.01). Thus, our datasets reflect a dynamic 
transcriptional program during EHT.
AGM highlighted the heterogeneous nature of the cells in 
the hematopoietic clusters (Ody et al., 1999; Taoudi et al., 2005; 
Yokomizo and Dzierzak, 2010; Robin et al., 2011). Whereas 
combinations of these markers allow HSC enrichment, so far 
no combination of endothelial and/or hematopoietic markers 
has been able to distinguish hemogenic from nonhemogenic 
aortic ECs.
The Ly6aGFP (Sca1) mouse model, in which all HSCs 
throughout development are GFP+ (de Bruijn et al., 2002; 
Ma et al., 2002), has facilitated the study of EHT. Clear proof 
of EHT was obtained by real-time imaging of the mouse 
Ly6aGFP embryonic aorta (Boisset et al., 2010). In the E10.5 
aorta, at the time when the number of hematopoietic clusters 
peak (Yokomizo and Dzierzak, 2010), flat endothelial GFP+ 
cells were observed to transition to morphologically round 
GFP+ cells that begin to express other HSC markers (Boisset 
et al., 2010). Real-time imaging of transgenic zebrafish em-
bryos similarly revealed the transition of aortic ECs to HCs 
(Bertrand et al., 2010; Kissa and Herbomel, 2010), indicating 
that EHT is an evolutionarily conserved process by which the 
definitive hematopoietic system of vertebrates is generated.
To specifically understand the molecular program involved 
in EHT, we set out in this study to identify key genes and 
processes that are functionally relevant in mouse aortic HECs 
as they transit to HSCs. Based on the vital imaging of EHT, 
the Ly6aGFP reporter is currently the most tractable marker 
to distinguish and enrich the HECs that are undergoing EHT 
from other aortic ECs, and also the emerging HSCs from 
other HCs. Here we present RNA sequencing data obtained 
from highly enriched small numbers of relevant EHT cells 
from Ly6aGFP embryos, aortic ECs, HECs, and emerging 
HSCs. Among the few (530) differentially expressed genes 
(DEGs) during EHT, Gpr56 is the highest up-regulated gene 
encoding a cell surface receptor. We show for the first time 
the functional involvement of Gpr56 in HSC emergence dur-
ing EHT. In addition, the previously described “heptad” tran-
scription factors (TFs; Wilson et al., 2010) are up-regulated 
during EHT, bind the Gpr56 enhancer, and regulate its expres-
sion. This unique dataset expands our understanding of EHT, 
identifying the gene networks and processes that are essential 
for HSC generation in the embryo.
RESULTS
Temporal-spatial and transcriptomic quantitation of aortic 
hemogenic endothelial and emerging HCs
Ly6aGFP expression marks HCs emerging from hemogenic 
endothelium at the time of HSC generation in the midgestation 
mouse aorta. To quantify and localize these cells, we performed 
confocal imaging of whole and sectioned immunostained 
E10 Ly6aGFP embryos (Fig. 1, A–D). CD31 marks all ECs 
and HCs, and cKit marks all HCs. However, Ly6aGFP marks 
only some ECs and some HCs. High-resolution imaging of 
transverse sections allowed quantitation of four different 
Ly6aGFP-expressing aortic cell types (Fig. 1 D): flat ECs, bulg-
ing cells in the single layer of endothelium, and two differently 
positioned round cells within the clusters distinguished by the 
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of the DEGs in HEC to HSC are down-regulated. Hierarchical 
clustering of DEGs grouped the three biological replicates of 
each fraction together, suggesting that ECs, HECs, and HSCs 
have recognizably distinct genetic programs (Fig. 2 D).
Transcriptome analysis reveals processes involved in EHT
DEGs were grouped based on their relative expression levels 
(H, high; I, intermediate; and L, low expression) into repre-
sentative patterns for EC genes (HIL, HLL, HHL, and HLI), 
HEC genes (LHL, IHL, IHI, and LHI), and HSC genes (LHH, 
LIH, IIH, LLH, and ILH; Fig. 3 and Table S2). Each group was 
used as input for Gene Ontology (GO), KEGG, and Wiki-
Pathways enrichment analysis, and Gene Set Enrichment Analy-
sis (GSEA) was used to detect global shifts of gene sets during 
each transition.
EC genes show overrepresentation of “focal adhesion,” 
“ECM-receptor interaction,” “protein digestion and absorp-
tion,” “oxidative stress,” and “chemokine signaling” terms (Fig. 3 A 
and Table S3), consistent with EC function (Rajendran et al., 
2013). Significant enrichment of “inflammatory response” 
Global transcriptional differences between  
the EHT cell subsets
Biological coefficient of variation (BCV) analysis indicates 
(Fig. 2 B) that EC, HEC, and HSC fractions are closely related 
but distinct. EC, HEC, and HSC replicate 2 and 3 samples 
cluster together, whereas replicate 1 EC, HEC and HSC sam-
ples show a similar BCV pattern but are further dispersed in 
the plot. The tighter sample dispersion of replicates 2 and 3 is 
most likely the result of the higher sequencing depth (Table S1). 
Hence, distinct transcriptional variation between the EHT 
fractions is consistent for the three biological replicates.
Dataset comparisons showed a total of 530 DEGs (false 
discovery rate [FDR] < 0.05; Fig. 2 C and Table S2). The EC 
to HEC comparison shows 139 DEGs, whereas 340 genes 
were differentially expressed between HECs and HSCs. More-
over, comparison of ECs with HSCs identified 108 additional 
genes. MA plots of differential expression analysis show most 
genes being centered around zero, further confirming the cor-
rect normalization of datasets (Fig. S2 A). In the EC to HEC 
comparison, most DEGs are up-regulated, whereas a majority 
Figure 1. Analysis of EHT cell subsets. (A) Whole-mount 
image of a 34-sp Ly6aGFP embryo showing expression of CD31 
(magenta), cKit (red), and GFP (green). The aorta, vitelline artery, 
and somatic vasculature are indicated. (B) Four types of aortic 
cells during EHT in a Ly6aGFP AGM section (36 sp) stained with 
anti-CD31 (magenta) and anti-cKit antibodies (red). ECs are 
CD31+cKitGFP, HECs are CD31+cKitGFP+, HSCs are 
CD31+cKit+GFP+, and HCs are CD31+cKit+GFP. (C) Transverse 
section through a 36-sp Ly6aGFP embryo showing expression 
of CD34 (red) and GFP (green). A hematopoietic cluster with 
some GFP+ cells is located ventrally. GFP+ ECs are scattered 
throughout the aorta. (D) Different GFP+ cell types (arrowheads) 
in an E10.5 Ly6aGFP aorta. (Endothelial) two flat GFP+ ECs; 
(bulging) rounding-up of a GFP+ EC; (juxtaposed) round HC 
closely adhering to an EC; (distal) round HC on the distal side of 
the cluster. The number of cells/aorta is listed below at the 32-, 
34-, and 37-sp stages. Bars: (A) 100 µm; (B and D) 10 µm;  
(C) 50 µm. (E) Scatter plot showing the distribution and sorting 
gates for EHT subsets EC, HEC, HSC, and HC from E10.5/E11 
Ly6aGFP AGMs. (F) Hematopoietic progenitor numbers (total 
CFU-C [CFU-culture]) per AGM. EHT subsets from E10.5 Ly6aGFP 
AGMs (34–39 sp) were plated in methylcellulose, and colonies were 
counted at day 12 (SD is shown; n = 4). (G) HSC long-term re-
populating activity in E11 Ly6aGFP AGM EHT subsets (40–49 sp). 
Irradiated adult recipients (n = 4) were injected with 5–9 ee  
of ECs, 4–9 ee of HECs, 1–5 ee of HSCs, and 4–8 ee of HCs to-
gether with 2 × 105 spleen cells (recipient type). Percentage of 
donor cell chimerism at 4 mo after injection is shown. Indicated 
above each bar is the number of repopulated recipients/number 
of recipients injected. (H) Normalized number of mapped frag-
ments for genes encoding the markers used for sorting EHT 
fractions. FPKMs of CD31, cKit, and Ly6aGFP per fraction are 
shown (error bars are SD). (I) Heat map of FPKMs for genes 
encoding several relevant cell surface molecules: Cdh5, Tek, 
Esam, Kdr, and Eng in each of the sequenced cell fractions and 
the frequency of cells in each sorted fraction expressing the 
corresponding protein. Significant positive correlation is ob-
served between FACS and RNAseq data (r2 = 0.54; **, P = 0.01).
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HECs as compared with ECs, whereas no significant enrich-
ment of these genes was found in HSCs as compared with 
HECs, indicating that the hematopoietic program is already 
activated in HECs (Fig. 4 A).
HSC genes showed clear overrepresentation of “hemato-
poietic processes,” “cell cycle,” and “histone methylation” related 
genes (Fig. 3 C). Significant enrichment of “cell cycle pro-
gression,” “DNA replication,” and “hematopoietic progeni-
tor” sets was also detected by GSEA (Fig. 4 A and Fig. S2 C). 
“Hematopoietic progenitor” gene sets are enriched in HSCs 
as compared with HECs, and detection of “acute myeloid 
leukemia” from the KEGG database and “pluripotency net-
work” from WikiPathways is in agreement with the acquisi-
tion of hematopoietic fate and self-renewal capacity in HSCs 
(Table S3). This is further supported by significant enrichment 
of gene sets characteristic of stem cells, such as “telomere 
lengthening” and “DNA repair,” in the HSC fraction by GSEA 
(Fig. 4 A; Yui et al., 1998; Rossi et al., 2005).
TF expression in cells undergoing EHT
The genetic program directing cell identity is coordinated 
by TFs, and thus we focused our attention on these genes 
in our EHT datasets. As compared with ECs, significant up-
regulated expression of Mecom, Notch1 and 4, Gfi1, Sox17, 
Ets2, and Elk3 was found in HECs (Table 1), with Sox7, 
Sox18, Runx1, Hhex, and Lmo2 among the top up-regulated 
HEC TFs (Table S4).
and “TGFbeta signaling” terms suggests ECs to be activated. 
Whether this is caused by activated endothelium in an actual 
inflammatory response or by the activation of inflammatory 
genes that are involved in other signaling pathways in devel-
opment (Orelio and Dzierzak, 2003; Orelio et al., 2009) requires 
further study.
HEC genes are most enriched in “cell adhesion” and “mi-
gration” gene sets, consistent with changes required for HECs 
to move out of the endothelial layer and form clusters of HCs 
(Fig. 3 B and Table S3). Like ECs, 169 out of 191 genes within 
the “angiogenesis” GO term (GO:0001525) were present in 
HECs. HEC genes also showed enrichment in “cardiovascu-
lar system development,” most likely because of the presence 
of many angiogenic and vascular development genes. Indeed, 
only 3 ( Jag1, Sox17, and Fbn1) out of the 76 published essen-
tial cardiovascular genes (Van Handel et al., 2012) are present 
in HEC genes. “Delta-Notch” and “Notch” pathways known 
to be important for HSC generation and cluster formation 
(Kumano et al., 2003) were enriched, and whole transcrip-
tome comparisons using GSEA also show Notch pathway 
gene sets as up-regulated in HECs (Fig. 4 A and Fig. S2 B). In 
addition, multiple “VEGF” and “hypoxia-regulated” gene sets 
were enriched in HECs as compared with HSCs and ECs 
(Fig. 4 A), including Hif1, which was recently shown to be 
an important factor for HSC generation (Imanirad et al., 
2014). Surprisingly, several previously published HSC gene 
sets (from MSigDB database v4.0) are significantly enriched in 
Figure 2. RNAseq data analysis. (A) Distribution of 
raw counts per sample (left) and edgeR internal normal-
ized counts (right). The normalized counts are used in all 
subsequent analyses. Datasets for three biological repli-
cates are shown for ECs, HECs, HSCs, and HCs. Biological 
replicate 1 includes two 36-sp and two 37-sp embryos; 
replicate 2 includes four 34-sp, two 35-sp, three 36-sp, 
and five 37-sp embryos; replicate 3 includes two 35-sp, 
one 36-sp, two 38-sp, one 39-sp, one 40-sp, and one  
41-sp embryos. (B) BCV in RNAseq samples from three 
biological replicates of relevant EHT cell fractions: EC, 
HEC, and HSC. (C) Venn diagram showing numbers of 
DEGs in comparisons of HECs versus ECs, HSCs versus 
HECs, and HSCs versus ECs. Total DEGs is 530 (see Table S2 
for gene lists). (D) Heat maps showing all 530 DEGs and 
hierarchical clustering of the genes in each EHT cell frac-
tion from the three biological replicates.
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of EHT. Our RNAseq datasets reveal that all heptad TFs 
increase during EHT (Fig. 5 A). To identify genes encoding 
novel EHT and embryonic HSC surface markers, the 530 
DEGs were compared with the 927 heptad TF targets identi-
fied by chromatin immunoprecipitation (ChIP)seq analyses in 
HPC7 cells. 58 DEGs were found to be targets of heptad TFs, 
with CD34 and Gpr56 as the top hits (Fig. 5, B and C). Inter-
estingly, also in the whole transcriptome analysis of EHT, Gpr56 
was identified as the top differentially expressed receptor gene 
in the HEC to HSC transition, followed by cKit (Fig. 4 B). 
Because both CD34 and cKit function has been studied in 
HSCs and these markers are used extensively for HSC isolation 
(Sánchez et al., 1996), we focused on Gpr56.
The Gpr56 heptad consensus region in the mouse is 
located 37 kb upstream of the translational start site. We iden-
tified this region as the Gpr56-37 enhancer. Enrichment of 
heptad factors at the Gpr56-37 element was found in mouse 
HPC7 cell line by quantitative PCR (qPCR; Fig. 5 D). Trans-
activation assays in hematopoietic progenitor cell lines showed 
significant activation of Gpr56-37 enhancer, whereas overex-
pression of three of the heptad factors (Gata2, Runx1, and Fli1) 
In the HSC fraction, many TFs with known roles in HSC 
development, including Etv6, Gfi1, Gfi1b, Myb, Myc, Hlf, 
Meis1, Hhex, Runx1, Mpl, and Ikzf1 and 2 (Table 1 and Table 
S4), were found to be significantly up-regulated as compared 
with ECs or HECs. We identified several novel TFs not previ-
ously reported to be involved in embryonic HSC generation 
such as zinc-finger proteins Zfp106, Zfp445, Zfp748, and 
Zfp763, megakaryocyte factor Nfe2, transcriptional corepres-
sor Bcor, and Cbfa2t3 (Eto2). Also present in the top hits were 
chromatin-remodeling factors Suz12, Paxip1, Kdm5a, Smarca4 
(Brg1), Ezh1, Bptf, and Hdac1 and de novo DNA methylation 
genes Dnmt3a/Dnmt3b and Dnmt1. The down-regulation of 
several Hox, Tbx, and Fox genes was observed in the EC to 
HEC and HEC to HSC transition, whereas only Hoxa9, Hhex, 
and Foxk1 were up-regulated in HSCs as compared with ECs 
or HECs (Table S4).
It has been shown that a pivotal (heptad) group of TFs 
work together in transcriptional regulatory complexes to reg-
ulate the expression of downstream target genes in hematopoi-
etic progenitor cell lines (Wilson et al., 2010). The heptad TFs 
could act as one of the transcriptional hubs for the regulation 
Figure 3. GO terms/processes enriched in EHT 
subsets. (A) DEG patterns that are EC specific are 
shown (left): high-intermediate-low (HIL), HHL, HLI, 
and HLL. GO enrichment analysis was performed 
using WebGestalt, and enriched GO terms are sum-
marized by REVIGO (right). (B) DEG patterns that are 
HEC specific are shown (left): LHL, IHL, IHI, and LHI. 
GO enrichment analysis and GO terms are summa-
rized by REVIGO (right). (C) DEG patterns that are HSC 
specific are shown (left): LHH, LIH, IIH, LLH, and ILH. 
GO enrichment and GO terms are summarized by 
REVIGO. Rectangle size represents the number of 
DEGs in the accompanying GO term. See Table S3 for 
enriched ontology terms.
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Gpr56 is highly conserved across different vertebrate species 
(mean multiple sequencing alignment score = 85%; Fig. 6 C). 
To validate the involvement of Gpr56 in HSC generation, 
we used a zebrafish morpholino oligo (MO) knockdown ap-
proach. At 30 and 48 h post fertilization (hpf), morphants were 
assayed by ISH (30 hpf ) for cmyb, a marker for emerging HSCs 
(Jing and Zon, 2011). WT embryos show cmyb-expressing 
cells along the aorta (Fig. 6 D). In contrast, cmyb-expressing 
cells are severely reduced in gpr56 MO–injected embryos. To 
validate that this was a defect in HSC generation, we injected 
the gpr56 MO into CD41-GFP transgenic embryos (CD41 
marks HCs; Lin et al., 2005; Jing and Zon, 2011; Robin 
et al., 2011). The number of CD41-GFP+ cells in the caudal 
hematopoietic tissue at 48 hpf is significantly decreased from 
36.7 ± 4.0 cells in WT to 12.5 ± 1.8 in gpr56 morphants 
(Fig. 6 E), suggesting that Gpr56 is important for the emer-
gence of HSCs. No abnormalities in embryo growth or the 
structure of the vasculature/aorta were found by ISH for arte-
rial endothelial marker gridlock (grl; Fig. 6 F; Zhong et al., 2000). 
To test whether the gpr56 MO does not show an off-target 
effect, we performed rescue experiments by injecting gpr56 
mRNA. Gpr56 morphants could be rescued with zebrafish 
showed synergistic activation of the Gpr56-37 enhancer (Fig. 5, 
E and F). Moreover, we identified a homologous element 
48 kb upstream of the human GPR56 gene. In human CD34+  
HSC-enriched cells, we found binding of all seven heptad 
TFs to the human GPR56-48 element (Fig. 5 G; Chacon 
et al., 2014). These data suggest that the heptad TFs and their 
downstream target Gpr56 are important in HSC generation 
during EHT, as well as in healthy and leukemic human HCs. 
Because nothing is known concerning Gpr56 in embryonic 
hematopoietic development, we examined its regulation and 
role during EHT.
Gpr56 is required during EHT for HSC generation
To confirm localized expression of Gpr56 in cells undergoing 
EHT, we performed in situ hybridization (ISH) analysis of the 
E10.5 AGM. High-level Gpr56 expression was observed in 
some aortic HCs (Fig. 6 A), and no/low expression was observed 
in aortic ECs. An overlap of Gpr56 expression with some 
GFP+ HCs was found by ISH of Ly6aGFP E10.5 AGM sec-
tions (Fig. 6 B). Thus, the localized expression of Gpr56 is 
consistent with FPKM values derived from RNAseq datasets 
and strongly suggests a role in HSC generation.
Figure 4. Changing processes and cell surface 
molecules during EHT. (A) GSEA for VEGF, Notch, 
Hypoxia up-regulated genes, genes specifically ex-
pressed in HSCs, stem cell function–related gene sets 
like “telomere lengthening” and “DNA repair,” cell 
cycle–related gene sets, and early hematopoietic 
progenitor–specific genes. (B) Receptor-related genes 
with significant expression changes in EC to HEC and 
HEC to HSC transitions. Blue, increased expression; 
red, decreased expression; gray font, genes with low 
overall expression levels as defined by edgeR-calculated 
logCPM of <3 (and higher probability of being false 
positive); asterisks, genes differentially expressed 
during both transitions; logFC, log fold change.
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Table 1. Differentially expressed TFs
HECs versus ECs HSCs versus HECs HSCs versus ECs
Gene logFC FDR Gene logFC FDR Gene logFC FDR
(A) Top 25 up-regulated genes
Elk3 2.42 1.1E-02 Myb 4.23 1.7E-06 Myb 4.55 7.1E-08
Mecom 3.21 1.4E-02 Gfi1b 5.48 7.7E-05 Ikzf2 3.13 2.5E-04
Notch4 5.41 2.9E-02 Hlf 7.03 8.9E-05 Hlf 5.99 6.7E-04
Notch1 2.16 4.2E-02 Meis1 2.20 8.1E-04 Runx1 2.68 1.8E-03
Rab11a 2.03 5.2E-02 Zfp106 2.43 3.5E-03 Myc 2.27 9.5E-03
Gfi1 7.69 6.8E-02 Ncoa4 2.05 8.8E-03 Dnmt3a 1.73 2.2E-02
Wwtr1 3.20 6.8E-02 Nop2 2.35 1.9E-02 Chd4 1.62 2.9E-02
Junb 4.90 6.8E-02 Elf1 2.51 2.0E-02 Dnmt1 1.58 3.2E-02
Ets2 2.50 6.9E-02 Zfp445 2.05 2.3E-02 Gfi1 8.33 3.3E-02
Mapk3 1.62 7.3E-02 Nfe2 5.05 4.1E-02 Zfp445 1.91 4.6E-02
Nkx2-3 5.95 7.4E-02 Zfp763 4.29 4.2E-02 Setbp1 2.78 5.9E-02
Ldb2 2.30 7.5E-02 Ikzf2 1.94 5.2E-02 Ikzf1 2.60 6.8E-02
Hdac7 2.20 7.6E-02 Huwe1 1.55 5.7E-02 Bcor 2.21 8.4E-02
Sox17 5.14 8.4E-02 Orc2 2.22 6.5E-02 Trp53bp1 1.51 8.5E-02
Ctnnb1 1.28 9.5E-02 Mpl 2.84 6.6E-02 Mycn 2.57 9.9E-02
Hey1 4.24 1.1E-01 Etv6 1.99 6.9E-02 Zfp106 1.67 1.0E-01
Epas1 3.10 1.2E-01 Lmo1 8.87 7.5E-02 Suz12 1.57 1.1E-01
Hey2 4.35 1.2E-01 Paxip1 1.93 7.6E-02 Cbfa2t3 2.63 1.2E-01
Sox7 4.27 1.5E-01 Cpsf6 1.28 8.1E-02 Paxip1 1.83 1.4E-01
Sox18 4.05 1.5E-01 Zfp748 2.68 8.3E-02 Notch1 1.72 1.4E-01
Tsc22d1 1.46 1.6E-01 Polr1a 2.41 8.3E-02 Etv6 1.82 1.5E-01
Nrarp 3.76 1.7E-01 Trp53bp1 1.42 8.9E-02 Kdm5a 1.38 1.5E-01
Nfic 2.07 1.8E-01 Dnmt1 1.29 9.4E-02 Meis1 1.22 1.8E-01
Pdlim1 1.96 2.1E-01 Med23 1.84 9.8E-02 Rreb1 1.49 1.8E-01
Hmg20b 2.46 2.1E-01 Krr1 1.45 1.0E-01 Bptf 1.17 1.8E-01
(B) Top 25 down-regulated genes
Pou5f1 7.70 2.6E-04 Snai2 7.39 7.7E-05 Snai2 8.64 3.0E-06
Utf1 8.22 1.0E-02 Id3 3.87 5.6E-04 Rhox6 10.09 2.9E-05
Gfi1b 3.77 1.3E-02 Hey2 7.55 2.3E-03 Rhox9 10.23 4.6E-05
Foxd1 10.54 6.6E-02 Rhox6 6.49 6.8E-03 Tgfb1i1 5.76 4.6E-05
Lmo1 10.20 6.7E-02 Msx2 8.54 7.4E-03 Pou5f1 7.16 2.2E-04
Hand1 6.55 7.4E-02 Rhox9 6.56 9.0E-03 Etv5 3.26 6.0E-04
Zfp612 7.77 1.0E-01 Etv5 2.60 1.1E-02 Utf1 8.47 3.6E-03
Prrx2 7.19 1.0E-01 Isl1 4.08 3.6E-02 Msx2 8.98 5.1E-03
Asb12 9.04 1.1E-01 Ebf2 7.43 4.0E-02 Id3 3.21 5.8E-03
Cdc6 1.75 1.3E-01 Ebf1 5.39 4.3E-02 Prrx2 10.99 6.9E-03
Ncoa4 1.48 1.4E-01 Hey1 4.69 4.4E-02 Prss35 5.99 1.8E-02
Krr1 1.47 1.4E-01 Epas1 3.42 4.6E-02 Grhl3 6.02 2.6E-02
Alx4 5.93 1.5E-01 Rarb 3.81 5.2E-02 Foxd1 10.54 2.8E-02
Wt1 4.76 2.0E-01 Hoxd9 7.63 5.5E-02 Ripk4 9.34 3.0E-02
Rhox2e 3.29 2.0E-01 Sox17 5.00 5.7E-02 Ebf2 8.08 3.0E-02
Pax8 8.85 2.1E-01 Creb3l1 4.59 5.8E-02 Foxp2 3.93 3.4E-02
Rhox6 3.59 2.2E-01 Ugp2 1.79 6.5E-02 Zim1 7.30 3.4E-02
Neurod6 6.02 2.2E-01 Nr3c1 2.93 6.9E-02 Creb3l1 5.25 3.5E-02
Hoxc4 8.73 2.3E-01 Notch4 4.21 7.1E-02 Hoxd9 8.66 3.6E-02
Rhox9 3.68 2.3E-01 Myt1 6.02 7.6E-02 Sall4 2.66 3.8E-02
Six1 7.30 2.3E-01 Elf3 6.86 7.6E-02 Id2 2.69 3.9E-02
(A and B) Top 25 up-regulated TFs (A) and top 25 down-regulated TFs (B) in HEC versus EC, HSC versus HEC, and HSC versus EC comparisons. FDR, FDR corrected p-value; 
logFC, log fold change. All genes with FDR < 0.05 except genes with underlining.
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To further study the function of Gpr56 in HSCs, we 
used the 32D-CSF3R cell line, a unipotent mouse stem cell 
differentiation model in which colony-stimulating factor-3 
stimulates their differentiation to neutrophils. (Fig. 6 H). 
When stimulated with CSF3, cells transduced with an empty 
vector or WT human GPR56 vector lost their blast charac-
teristics and differentiated. However, cells transduced with 
constitutively active (MUT) human GPR56 resulted in an in-
crease in blast-like cells and in significantly fewer differentiated 
gpr56 mRNA, as well as with a mouse Gpr56 mRNA to 
yield full restoration of aortic cmyb expression (Fig. 6 G). Inter-
estingly, some ectopic expression of cmyb is observed in the 
region ventral to the aorta. These data indicate that gpr56 is 
an essential player in the HSC generation program and that 
its functional domains are maintained between mouse and 
zebrafish. Ectopic generation of phenotypic HSCs in zebrafish 
by Gpr56 overexpression further highlights the unexpected 
function of this molecule in induction of HSC generation.
Table 1. (Continued)
HECs versus ECs HSCs versus HECs HSCs versus ECs
Gene logFC FDR Gene logFC FDR Gene logFC FDR
Tcf21 5.63 2.3E-01 Ankrd1 4.84 7.7E-02 Hoxc10 5.83 5.0E-02
Runx1t1 1.79 2.4E-01 Onecut3 8.32 8.3E-02 Myt1 6.64 6.7E-02
Klf1 6.56 2.6E-01 Hivep3 5.19 8.4E-02 Elf3 7.56 6.9E-02
Aff3 3.18 3.1E-01 Zfp36l1 1.90 8.6E-02 Isl1 3.79 7.0E-02
(A and B) Top 25 up-regulated TFs (A) and top 25 down-regulated TFs (B) in HEC versus EC, HSC versus HEC, and HSC versus EC comparisons. FDR, FDR corrected p-value; 
logFC, log fold change. All genes with FDR < 0.05 except genes with underlining.
Figure 5. Gpr56 is a heptad target in mouse and  
human blood progenitors. (A) Mean FPKM values of heptad 
factors in EC, HEC, and HSC fractions. (B) A Venn diagram 
showing the overlap between sites with combinatorial bind-
ing of Scl, Gata2, Runx1, Erg, Fli1, Lyl1, and Lmo2 in HPC7 
cells (Heptad targets) and 530 DEGs during EHT. (C) Heat 
map of top 10 heptad target DEGs based on highest expres-
sion in HSCs and with respective mean FPKM values inside 
heat map. (D) qPCR for TF enrichment at Gpr56-37 as com-
pared with IgG and control in HPC7 mouse myeloid progeni-
tor cells (n = 4). (E) Transfection assays in 416B and HPC7 
mouse progenitors show enhancer activity of Gpr56-37 (n = 3). 
(F) Transactivation assays in Cos7 cells showing synergistic 
responsiveness of the Gpr56-37 element to Runx1, Gata2, 
and Fli1 (n = 4). (D–F) Error bars show SD. (G) TF binding at 
HsGPR56-48 (corresponding region to MmGpr56-37) in 
primary human CD34 HSCs.
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program begins in HECs, further distinguishing them from 
ECs. Of the 530 DEGs, important receptors and TF genes 
were identified, including Gpr56, which is required for HSC 
formation. Moreover, the heptad (hematopoietic) TFs were 
found to be up-regulated during EHT. These factors bind the 
Gpr56 enhancer and regulate its expression, thus providing a 
proof of principle for in silico bioinformatical predictions of 
the combinatory role of the heptad TFs in the emergence of 
HSCs during EHT. Thus, our datasets are predictive of func-
tionally relevant EHT genes and processes.
RNAseq analysis of small numbers of physiologically 
relevant cells
The Ly6aGFP transgenic marker in combination with CD31 
and c-Kit cell surface markers allowed the high enrichment of 
HSCs, HECs, and ECs isolated from the aorta at the develop-
mental time when HSCs begin to emerge. Imaging experi-
ments verified the correlation between these markers, the 
expected cell type, and localization within the AGM region. 
cells (eight- to fourfold fewer), suggesting that GPR56 is 
also essential for the maintenance of an undifferentiated 
cell state.
DISCUSSION
RNA sequencing analyses of EHT and developing HSCs 
provide a new perspective on the molecules and processes. 
Whereas previous methods of transcriptome analysis have 
identified many of the obvious regulators of hematopoietic 
development, this method provides an accurate accounting of 
all expressed genes and also small gene expression level changes 
between the rare, relevant cell types. We have shown here that 
HECs (the precursors of the earliest emerging HSCs in the 
midgestation mouse aorta), as distinguished from other ECs 
by Ly6aGFP expression, have closely related but distinct tran-
scriptional programs. Comparisons between ECs and HECs 
reveal a developing program indicative of cell migration and 
changing cell morphology in HECs, while they retain an angio-
genic program. The up-regulation of the HSC hematopoiesis 
Figure 6. In silico and in vivo analysis of Gpr56. (A) ISH 
of WT mouse E10.5 AGM sections shows specific expression of 
Gpr56 in some HCs, a few cells lining the aorta (Ao), and the 
notochord (NT). The top images show low magnification of 
AGM cross-section, and the bottom images show high magni-
fication of the boxed areas. (B) ISH of E10.5 Ly6aGFP AGM 
shows coexpression of GFP and Gpr56 in some HCs. (C) Ho-
mology relationships of the Gpr56 coding sequence of differ-
ent vertebrate species. (D–F) Analysis of WT and gpr56 MO 
zebrafish for the presence of HSCs. (D) ISH with the HSC 
marker cmyb at 30 hpf. (E) Fluorescent analysis of WT and MO-
injected CD41:GFP transgenic embryos at 48 hpf. Numbers in 
the panels indicate the number of embryos with the depicted 
phenotype. Arrowheads (left) indicate CD41-expressing HCs in 
the aorta. The dashed lines (right) indicate the outline of the 
morphant zebrafish embryo for orientation purposes. (F) ISH 
with arterial cell marker grl. No vascular or developmental 
abnormalities can be observed in gpr56 morphant embryos. 
(G) HSC rescue of gpr56 morphant zebrafish with gpr56 RNA 
(zebrafish and mouse) as shown by ISH for cmyb. Ectopic cmyb 
expression in the posterior cardinal vein is clearly visible. No 
vascular abnormalities can be observed by grl ISH. (D and G) 
Insets show boxed areas at higher magnification. Bars: (A)  
30 µm; (B) 10 µm; (D–G) 100 µm. (H) Effect of human GPR56 
activity in neutrophil differentiation of the 32D-CSF3R unipo-
tent stem cell line. 32D-CSF3R cells cultured in medium con-
taining CSF3 efficiently differentiated into neutrophils. Only 
constitutive active mutant GPR56 (MUT) could block differen-
tiation. Diff ct, differential count; Cntl, empty vector control; 
WT, WT human GPR56 vector; mut, constitutively active  
human GPR56 mutant vector; Bl, blast morphology; In, inter-
mediate morphology; Ne, neutrophil morphology.
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enrichment of “hematopoiesis” and “positive regulation of 
histone methylation” terms.
HECs are a transcriptionally dynamic cell type at the 
interface of EHT. Concurrent with the initiation of the 
hematopoietic program and HC formation, hematopoietic 
genes become activated in HECs, whereas endothelium-specific 
cell adhesion molecules and TFs are down-regulated in HSCs. 
Our RNAseq data are in agreement with the recent single-
cell high-throughput qPCR analysis results for 18 known 
endothelial and hematopoietic genes during EHT (Fig. S2 D; 
Swiers et al., 2013). We also identified several genes involved 
in angiogenesis by selection for GO term “receptor activity” 
in HEC versus EC comparisons (Fig. 4 A). These include 
Plxnd1, Eltd1, Calcrl, Ramp2, and S1pr1; Plxnd1 and Eltd1 are 
both induced by VEGF (Kim et al., 2011; Masiero et al., 
2013). Calcrl, a GPCR, induces angiogenesis upon association 
with Ramp2 and Kdr/Vegf-r2, both of which are signifi-
cantly induced in HECs (Guidolin et al., 2008). Collectively, 
these findings suggest a role for angiogenesis-related recep-
tors in activation of hematopoietic potential and generation 
of HECs.
GPR56: a novel EHT regulator
Gpr56, one of the top hits in our HSC versus HEC compari-
son (30-fold increase) and bound by all heptad TFs, is indeed 
a novel regulator for emerging HSCs in the embryonic vas-
culature. Contrary to expectations raised by the lack of HSC 
defects in mouse Gpr56 KO embryos (generated by deletion 
of the first two exons [Saito et al. 2013]), our RNAseq data 
suggested a strong role for Gpr56 in emergence of HSCs. In 
the E10.5 mouse aorta, we localized Gpr56 expression to a few 
HCs/HSCs (Ly6aGFP+). Upon gpr56 knockdown, zebraf-
ish embryos showed severe reduction in HSCs (cmyb) and 
CD41+ hematopoietic stem/progenitor cells, revealing a re-
quirement for Gpr56 in HSC generation. Our rescue ex-
periments in gpr56 morphants show that both zebrafish and 
mouse Gpr56 RNA can restore aortic hematopoietic stem/
progenitor generation. Moreover, Gpr56 overexpression re-
sulted in ectopic hematopoietic progenitor/stem cell forma-
tion in the axial vein, suggesting that the Gpr56 signaling axis 
may be useful for inducing new HSCs.
We propose that the lack of embryonic lethality in Gpr56 
KO embryos could be the result of redundancy by other 
GPCRs or residual Gpr56 activity in the mouse transgenic 
model. Our RNAseq and RT-qPCR validation (Fig. S2 E) 
data show an increase in the expression of Gpr114 (77 kb up-
stream of Gpr56) and Gpr97 (48 kb downstream) during 
EHT. The ligand binding N-terminal part of Gpr114 has 47% 
amino acid similarity (and 27% identity) with Gpr56. Gpr114 
is present only in mammals. Also, assays testing a human Gpr56 
variant missing a large part of the second exon and the com-
plete third exon showed that it partially retains the ability to 
activate SRE, E2F, NFAT, and iNOS promoters (Kim et al., 
2010). Thus, Gpr56 is an unexpected novel EHT regulator 
essential for HSC generation and maintenance, and its func-
tion is conserved between mouse and zebrafish.
Moreover, we confirmed that functional adult-repopulating 
HSCs are exclusively contained within the HSC fraction 
(0.002% of AGM cells) and that both endothelial fractions (ECs 
and HECs) do not contain hematopoietic progenitors or HSCs. 
Thus, the Ly6aGFP marker currently allows the highest level 
of enrichment for HECs (Fig. S1 B) that will undergo transi-
tion to HSCs, as compared with previously used markers.
Previous comparative HSC gene expression profiling 
(microarray) studies identified several new regulators of AGM 
HSCs, but the genetic program of HECs was not examined 
(Mascarenhas et al., 2009; McKinney-Freeman et al., 2012). 
During preparation of this manuscript, a new microarray 
study of EHT-relevant populations was performed based on 
cells expressing the Runx1+23-enhancer marker (Swiers et al., 
2013). Runx1+23GFP marks 68% of VE-cadherin+ (endo-
thelial and hematopoietic) cells at E8.5, marking many HECs 
that are not as yet exhibiting EHT. However, Ly6aGFP 
expression marks only a small fraction (13–19%) of CD31+ 
aortic cells and is probably more specifically marking the active 
HECs at E10.5.
Given the limited number of cells in our enriched aortic 
EC, HEC, and emerging HSC fractions, RNA sequencing 
provides the most efficient and sensitive method for analysis 
of EHT-relevant cells. Only 4–14 embryos (aortas) were used 
per sequencing experiment to isolate sufficient quantities of 
total RNA from sorted cell populations. With as few as 593 
sorted cells, we successfully applied RNAseq technology with 
the SMARTER protocol, recently shown to be the best 
RNAseq method for low numbers of cells (Bhargava et al., 
2014). Additionally, RNAseq analysis has the great advantage 
over microarrays in not only providing the whole transcrip-
tome, but also revealing isoform-specific transcripts in the 
sequenced samples. For example, Gpr56 expresses two tran-
script variants. We found variant 1 (GenBank accession no. 
NM_001198894) of Gpr56 to be expressed exclusively in 
HSCs, whereas variant 2 (GenBank accession no. NM_018882) 
was expressed in ECs, HECs, and HSCs. Variant 2 was more 
highly represented in HSCs (FPKM = 323) as compared with 
variant 1 (FPKM = 52).
Identification of processes involved in EHT
For the first time, datasets from aortic ECs, HECs, and HSCs 
provide an overview of the general processes involved during 
EHT. Quantitative levels of gene expression between EHT-
enriched cell fractions show only a small number of signifi-
cant DEGs: 139 between HECs versus ECs and 340 between 
HSCs versus HECs. Not surprisingly, the genes with high 
expression in midgestation aortic ECs are mainly those in-
volved in “general developmental processes.” These and other 
GO categories related to cell migration and focal adhesion 
are highly represented in HECs, highlighting the fact that 
HECs must change their adhesive properties to bulge out of 
endothelial lining of the aorta, undergo morphological 
changes as they become HCs, adhere to other HCs within the 
clusters, and take on hematopoietic identity and function. GO 
analysis of DEGs with the highest expression in HSCs shows 
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incubation in H2O2. After developing color for several days, sections were 
washed five times for 30 min in PBS-0.1% Tween (Tw) and mounted in Kaiser’s 
Glycerol gelatin (Merck). Ly6aGFP sections were incubated overnight at room 
temperature with rabbit polyclonal anti-GFP (1:1,000; Abcam) in PBSBlock 
(1% BSA, 0.05% Tw), washed in PBS+ (0.05% Tw), and incubated for 30 min 
at room temperature with polyclonal biotinylated GantiRIg (1:400; Dako) in 
PBSBlock, washed, incubated for 30 min at room temperature with Streptavidin-
HRP (PK-7100; Vector Laboratories), washed, and color developed at room 
temperature in the dark by 6-min incubation in 4 ml of 5% (wt/vol) diami-
nobenzidine (Fluka) and 200 ml PBS. 70 µl of 35% H2O2 was added to start 
the reaction. Slides were rinsed with tap water, mounted, and imaged on 
a BX40F4 microscope and Colorview IIIu camera (Olympus). Sense control 
probes showed no signal.
Hematopoietic assays. Sorted cells were plated in triplicate in methylcellu-
lose (MethoCult GF; STEMCELL Technologies) with 1% PS and incubated at 
37°C, 5% CO2 for 12 d. Hematopoietic colony types were distinguished by 
morphology and counted with an inverted microscope.
For all transplantations, 9-Gy irradiated (split dose) C57BL/6 female 
recipients were used. 2 × 105 C57BL/6 spleen cells were coinjected with 
the sorted cell samples. Chimerism in hematopoietic tissues was assessed 
by semi-qPCR for the GFP transgene (eGFP FW 5-AAACGGCCA-
CAAGTTCAGCG-3 and RV 5-GGCGGATCTTGAAGTTCACC-3), 
normalized to myogenin (Myo FW 5-TTACGTCCATCGTGGACAGC-3 
and RV 5-TGGGCTGGGTGTTTAGTCTTA-3). Control mixes of 
Ly6aGFP and WT DNA were used to make a standard curve, and the trend 
line formula was used to calculate the percentage of reconstitution of each 
sample. Peripheral blood cell donor chimerism was assayed at 1 and 4 mo 
after injection, and mice were sacrificed for analysis of donor chimerism 
in all hematopoietic tissues. Recipients considered reconstituted are ≥10% 
donor chimerism positive. All experiments have been conducted according 
to Dutch law and have been approved by the animal experiments committee 
(Stichting DEC consult, Dier Experimenten commissie, protocol numbers 
138-11-01 and 138-12-13).
RNA isolation. Cells (see Table S1) were directly sorted into PBS/10% 
FCS/1% PS and centrifuged, and supernatant was removed. Cells were lysed, 
and RNA was isolated using the mirVana miRNA Isolation kit (Ambion) 
according to the manufacturer’s protocol. RNA quality and quantity were 
measured by the 2100 Bioanalyzer (Agilent Technologies).
mRNA sequencing analysis. RNA samples (Table S1) were prepared by 
SMARTer protocol. Illumina TrueSeq v2 protocol was used on HiSeq2000 with 
single read of 36 bp + 7 bp index. Reads were aligned to the mouse genome 
(NCBI37/mm9) using Tophat/Bowtie and mapped to the mouse genome 
(NCBI37/mm9), and the generated count table was analyzed by R/Biocon-
ductor package edgeR according to McCarthy et al. (2012). Counts were 
normalized for mRNA abundance, and differential expression analysis was 
performed using edgeR (Fig. 2 A). B-H method was used for p-value correction 
with an FDR of 0.05 as statistically significant. Variance stabilized counts 
were calculated by R/Bioconductor package “DESeq” for all the genes 
(Anders and Huber, 2010). Heat maps were generated from the log-scaled 
variance stabilized counts of DEGs. GSEA was performed using the 
preranked option in combination with log fold change values of each com-
parison calculated by edgeR. Cufflinks was used to compute transcript 
abundance estimates in FPKMs (Trapnell et al., 2013). For DEGs, the FPKMs 
for each gene across all samples were normalized by division with maximum 
FPKM observed for that gene. Patterns were generated based on normalized 
FPKM, with expression levels lower than 1/3 assigned as low (L), between 
1/3 and 2/3 as intermediate (I), and more than 2/3 as high (H). Patterns were 
then categorized as ECs, HECs, or HSCs. Genes corresponding to EC, HEC 
or HSC patterns were separately used for GO, KEGG, and Phenotype 
ontology enrichment analysis using the WebGestalt web application (Wang 
et al., 2013). GO terms were summarized using the REVIGO tool (Supek 
et al., 2011).
How Gpr56 acts in HECs as they transdifferentiate to 
HSCs is unknown, but it could affect physical properties such 
as adherence, cluster formation, signal transduction, migra-
tion, and/or self-renewal. Some of these features are consis-
tent with findings in neuronal stem cells, BM HSCs, and 
leukemic cells, in which it has been proposed that Gpr56 
functions in cell adhesion, migration, and/or repression of 
apoptosis (Iguchi et al., 2008; Saito et al., 2013). We found 
that Gpr56 functions in the maintenance of the undifferenti-
ated state of a unipotential HSC line. The conservation of 
Gpr56 across species will allow for future high-throughput 
study of the mechanism by which Gpr56 affects EHT and 
generation of HSCs.
Our results on heptad TF binding to the Gpr56 enhancer 
suggest that other heptad targets in the overlapping list are 
likely to be relevant in EHT. However, not all genes that we 
identified as highly up-regulated during EHT are targets of 
the heptad complex, for example cKit. Because EHT regula-
tion is likely to be multilayered, we are using our whole tran-
scriptome dataset as a resource to identify other candidate 
transcriptional hubs.
In summary, novel and known EC, HEC, and HSC genes 
were identified in our RNAseq datasets. These comparative 
quantitative data have high predictive value for identifying func-
tionally important molecules that direct the cellular processes 
involved in EHT and could instruct methods for de novo 
HSC generation either by direct somatic cell conversion or 
pluripotent stem cell differentiation.
MATERIALS AND METHODS
Cell preparation and flow cytometry. Ly6aGFP and WT mouse embryos 
were dissected as described previously (Robin and Dzierzak, 2010), and single 
cells were prepared by collagenase treatment (0.125%, 45 min, 37°C) and 
washed with PBS, 10% heat-inactivated FCS, and 1% penicillin/streptomycin 
(PS). Cells were stained with RMCD31-AF647 (1:400; BioLegend) and 
RMcKit-PE (1:1,200; BD) for 30 min at 4°C, washed with PBS/10% FCS/1% 
PS, and analyzed/sorted on a FACSAria III or SORP FACSAria II (BD).
Mouse embryo immunostaining and imaging. 10-µm cryosections 
were prepared as described in Ling et al. (2004; except last dehydration steps 
were omitted), stained with RMCD34-biotin (1:100; BD) and Streptavidin-
Cy5 (1:500; Jackson ImmunoResearch Laboratories, Inc.), and imaged on an 
SP5 confocal microscope (Leica).
Whole-mount embryos were prepared as described previously (Yokomizo 
et al., 2012), stained with RM-cKit (1:500; eBioscience) and Rat–
Alexa Fluor 647 (1:5,000; Invitrogen), RMCD31-biotin (1:500; BD) and 
Streptavidin–Alexa Fluor 555 (1:500; Invitrogen), RGFP (1:2,000; MBL) 
and GR–Alexa Fluor 488 (1:1,000; Invitrogen), and imaged on an SP5 
microscope. 1.48 µm between stacks; 17 stacks (23.7 µm) merged.
For ISH, embryos (36 sp) were fixed and rotated overnight, 4°C in 4% 
paraformaldehyde, washed three times in PBS at 4°C, and embedded in par-
affin, followed by overnight ethanol dehydration and two xylene washes 
using a Histokinette (Microm HMP110). 10-µm sections were obtained 
using a microtome. For Gpr56 cRNA probes, the mouse coding sequence 
(942 bp) was primed from BM cDNA with FW 5-TTGCAGCAGCT-
TAGCAGGTA-3 and RV 5-GATAGCCGGGCACATAGGTA-3 oligos, 
and the fragment was ligated to pGEM-T Easy (Promega) and linearized be-
fore sense and -sense probes synthesis: overnight at room temperature with 
DIG-dUTP mix (Roche) and SP6/T7 polymerases (Roche). Hybridization 
was performed as described previously (Ciau-Uitz et al., 2000), without 
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Primers. For cloning: Gpr56-37F, 5-GAGGATCCTCCATGAGGGA-
CATCTTCAA-3; Gpr56-37R, 5-AGTCGACACGGGCTTATCACGAGA-
AAT-3. For ChIP-qPCR: Gpr56-37F, 5-AATGTTATCAACCGTCTGC-3; 
Gpr56-37R, 5-CCTCACCTAATCAAGATATGTC-3. For RT-qPCR vali-
dations: Gpr56 FW, 5-GCAGAACACCAAAGTCACCA-3; Gpr56 RV, 
5-TGTCTCTGCTCACTGTCTCG-3; Gpr97 FW, 5-CTGGGATATG-
GCTAAAGGAGAC-3; Gpr97 RV, 5-AAGGCGAAGAAGGTCAAGTG-
3; Gpr114 FW, 5-TCACTGCTCAATAACTATGTCC-3; Gpr114 RV, 
5-ACTGTATACCCTTCCAGACTC-3; Ikzf2 FW, 5-AGCCCTTCAAAT-
GTCCTTTCTG-3; Ikzf2 RV, 5-CAGCGTTCCTTGTGTTCCTC-3; 
Meis1 FW, 5-CATCTTTCCCAAAGTAGCCAC-3; Meis1 RV, 5-GTA-
AGTCCTGTATCTTGTGCC-3; Mpl FW, 5-TTGGACTTCAGTGCTT-
TACCT-3; Mpl RV, 5-CTCCTCTTCACATTTCTCCCA-3; Mycn FW, 
5-GGAGAGGATACCTTGAGCGA-3; Mycn RV, 5-GGTTACCGCCTT-
GTTGTTAGAG-3; Gata2 FW, 5-CACCCCTAAGCAGAGAAGCAA-3; 
Gata2 RV, 5-TGGCACCACAGTTGACACACT-3; Gata3 FW, 5-TGT-
GGGCTGTACTACAAGCT-3; Gata3 RV, 5-TCGATTTGCTAGA-
CATCTTCCG-3; Runx1 FW, 5-CAGGTAGCGAGATTCAACGA-3; 
Runx1 RV, 5-TTTGATGGCTCTATGGTAGGTG-3; Hlf FW, 5-CG-
CAAAGTCTTCATTCCCGA-3; Hlf RV, 5-GCTCCTTCCTTAAAT-
CAGCCA-3; Gapdh FW, 5-GACTTCAACAGCAACTCCCA-3; Gapdh 
RV, 5-GCCGTATTCATTGTCATACCAG-3.
Online supplemental material. Fig. S1 provides FACS characterization of 
CD31+ AGM cells and a representative multilineage repopulation analysis 
of transplanted mice. Further details of RNAseq analyses and a compari-
son with the published single-cell qPCR analysis of EHT cells (Swiers et al. 
2013) and adult BM HSCs (Riddell et al. 2014) is provided in Fig. S2. 
Table S1 contains details of the material used for RNAseq analysis. Table 
S2 contains the 530 DEGs and their expression patterns and groupings. 
Ontology enrichment analysis results for each group are provided in Table 
S3. Table S4 contains a list of up- and down-regulated TFs as found by 
differential expression analysis with edgeR. All sequencing data has been 
uploaded to GEO repository under accession number GSE63316. Online 
supplemental material is available at http://www.jem.org/cgi/content/full/ 
jem.20140767/DC1.
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